title: Evolving role of adiponectin in cancer-controversies and update.
abstract: Adiponectin (APN), an adipokine produced by adipocytes, has been shown to have a critical role in the pathogenesis of obesity-associated malignancies. Through its receptor interactions, APN may exert its anti-carcinogenic effects including regulating cell survival, apoptosis and metastasis via a plethora of signalling pathways. Despite the strong evidence supporting this notion, some work may indicate otherwise. Our review addresses all controversies critically. On the whole, hypoadiponectinaemia is associated with increased risk of several malignancies and poor prognosis. In addition, various genetic polymorphisms may predispose individuals to increased risk of obesity-associated malignancies. We also provide an updated summary on therapeutic interventions to increase APN levels that are of key interest in this field. To date efforts to manipulate APN levels have been promising, but much work remains to be done.
authors.affiliation: UCL Medical School, UCL Faculty of Medical Science, University College London, London WC1E 6BT, UK.
authors.forename: Arnav
authors.initials: A
authors.lastname: Katira
authors.affiliation: UCL Medical School, UCL Faculty of Medical Science, University College London, London WC1E 6BT, UK; Breast Unit, Whittington Health, London N19 5NF, UK.
authors.forename: Peng H
authors.initials: PH
authors.lastname: Tan
keywords: Adiponectin; cancer; therapeutic target